- What’s new in molecular genetic pathology 2022: immune checkpoint inhibitor biomarkers and select solid tumors
-
Tsang PC, Chen G
- KMID: 2527198
- J Pathol Transl Med.
- 2022 Mar;56(2):113-114.
- doi: 10.4132/jptm.2022.01.25
Predictive biomarker testing plays a critical role in targeted immuno-oncology, including the use of immune checkpoint inhibitors (ICI) for various solid tumors. Molecular advancements in cancers of the breast, kidney... -
- CITED
-
- Close
- SHARE
-
- Close
- What’s new in molecular genetic pathology 2021: solid tumors and NGS panel selection
-
Chen G, Tsang PC
- KMID: 2522446
- J Pathol Transl Med.
- 2021 Nov;55(6):421-422.
- doi: 10.4132/jptm.2021.09.01
The linchpin of precision medicine is molecular genetic and genomic testing. Molecular biomarkers are important for establishing precise diagnoses and for predicting therapeutic responses that enable cancer patients to receive... -
- CITED
-
- Close
- SHARE
-
- Close
